MacroGenics
MGNX
#9332
Rank
C$0.21 B
Marketcap
C$3.35
Share price
0.84%
Change (1 day)
49.91%
Change (1 year)

EPS for MacroGenics (MGNX)

EPS in 2026 (TTM): C-$0.77

According to MacroGenics's latest financial reports the company's current EPS (TTM) is C-$0.80. In 2025 the company made an earnings per share (EPS) of C-$1.65 a decrease over its 2024 EPS that were of C-$1.50.

EPS history for MacroGenics from 2011 to 2026

Annual EPS

Year EPS Change
2026 (TTM)C-$0.77-53.57%
2025C-$1.6510.28%
2024C-$1.50613.33%
2023C-$0.21-92.31%
2022C-$2.72-42.14%
2021C-$4.7136.44%
2020C-$3.45-21.84%
2019C-$4.42-24.58%
2018C-$5.85675.93%
2017C-$0.75-68.05%
2016C-$2.36168.25%
2015C-$0.88-55%
2014C-$1.963400%
2013C-$0.05589-108.68%
2012C$0.6424.49%
2011C$0.52

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
C$1.06-233.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
C$41.76-5,342.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
C$22.66-2,945.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
C-$3.63 356.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
C$1.77-322.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
C$6.34-896.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Xencor
XNCR
C-$3.03 280.70%๐Ÿ‡บ๐Ÿ‡ธ USA